Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Ayton

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Nature Reviews. Neurology|April 20, 2022
Ventricular enlargement caused by aducanumabScott Ayton
European Journal of Neurology|July 5, 2021
Brain volume loss due to donanemabScott Ayton
Science Bulletin|September 27, 2023
TRIMming the tanglesPeng Lei, Scott Ayton
Plos Medicine|January 20, 2026
Missing tissue, missing data: Resolving brain volume loss caused by anti-amyloid therapiesFrancesca Alves, Scott Ayton
Biomed Research International|February 15, 2014
Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegenerationScott Ayton, Peng Lei
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
The Aβ-induced NFAT apoptotic pathway is also activated by GSK-3 inhibition: implications for Alzheimer therapeuticsScott Ayton, Peng Lei
Ageing Research Reviews|November 14, 2020
β-amyloid: The known unknownsScott Ayton, Ashley I Bush
The Lancet. Neurology|June 17, 2019
Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegenerationScott Ayton, Ashley I Bush
Neurology|March 27, 2023
Accelerated Brain Volume Loss Caused by Anti-β-Amyloid Drugs: A Systematic Review and Meta-analysisFrancesca Alves, Pawel Kalinowski, Scott Ayton
The Lancet. Neurology|February 22, 2025
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priorityScott Ayton, Robert Howard, Madhav Thambisetty
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Nature Reviews. Neurology|April 20, 2022
Ventricular enlargement caused by aducanumabScott Ayton
European Journal of Neurology|July 5, 2021
Brain volume loss due to donanemabScott Ayton
Science Bulletin|September 27, 2023
TRIMming the tanglesPeng Lei, Scott Ayton
Plos Medicine|January 20, 2026
Missing tissue, missing data: Resolving brain volume loss caused by anti-amyloid therapiesFrancesca Alves, Scott Ayton
Biomed Research International|February 15, 2014
Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegenerationScott Ayton, Peng Lei
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2012
The Aβ-induced NFAT apoptotic pathway is also activated by GSK-3 inhibition: implications for Alzheimer therapeuticsScott Ayton, Peng Lei
Ageing Research Reviews|November 14, 2020
β-amyloid: The known unknownsScott Ayton, Ashley I Bush
The Lancet. Neurology|June 17, 2019
Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegenerationScott Ayton, Ashley I Bush
Neurology|March 27, 2023
Accelerated Brain Volume Loss Caused by Anti-β-Amyloid Drugs: A Systematic Review and Meta-analysisFrancesca Alves, Pawel Kalinowski, Scott Ayton
The Lancet. Neurology|February 22, 2025
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priorityScott Ayton, Robert Howard, Madhav Thambisetty
Pageof 15